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GUIDELINES AND RESOURCES  
  
Updated Interim Case Definition for Human Monkeypox,  
January 2004  
  
The previous case definition (published July 2, 2003) has been updated as follows:  
• Exclusion criteria have been revised  
• Probable case classification has been edited  
 
  
Clinical Criteria  
Rash (macular, papular, vesicular, or pustular; generalized or localized; discrete or confluent)  
  
Fever (subjective or measured temperature of >99.3° F [> 37.4° C])  
  
Other signs and symptoms   
 • Chills and/or sweats   
 • Headache   
 • Backache   
 • Lymphadenopathy   
 • Sore throat   
 • Cough   
 • Shortness of breath  
 
  
Epidemiologic Criteria   
 • Exposure
1
 to an exotic or wild mammalian pet
2
 obtained on or after April 15, 2003, with clinical 
signs of illness (e.g., conjunctivitis, respiratory symptoms, and/or rash)   
 • Exposure
1
 to an exotic or wild mammalian pet
2
 with or without clinical signs of illness that has 
been in contact with either a mammalian pet
3
 or a human with monkeypox  
 • Exposure
4
 to a suspect, probable, or confirmed human case of monkeypox   
 
  
Laboratory Criteria  
 • Isolation of monkeypox virus in culture   
 • Demonstration of monkeypox virus DNA by polymerase chain reaction testing of a clinical 
specimen   
 • Demonstration of virus morphologically consistent with an orthopoxvirus by electron microscopy 
in the absence of exposure to another orthopoxvirus   
 • Demonstration of presence of orthopoxvirus in tissue using immunohistochemical testing methods 
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Case Classification  
Suspect Case   





 • Fever or unexplained rash AND two or more other signs or symptoms with onset of first sign or 




Probable Case  
 • Meets one of the epidemiologic criteria   
 
AND  
 • Fever  
 
AND  
• Vesicular-pustular rash with onset of first sign or symptom <21 days after last exposure meeting 




•  If rash is present but the type is not described, demonstrates elevated levels of IgM antibodies 
reactive with orthopox virus between at least days 7 to 56 after rash onset5  
 
  
Confirmed Case  
 • Meets one of the laboratory criteria   
 
  
Exclusion Criteria A case may be excluded as a suspect or probable monkeypox case if:  
 • An alternative diagnosis can fully explain the illness
6  
OR  
 • The case was reported on the basis of primary or secondary exposure to an exotic or wild 
mammalian pet or a human (see epidemiologic criteria) subsequently determined not to have 
monkeypox, provided other possible epidemiologic exposure criteria are not present OR  
 • A case without a rash does not develop a rash within 10 days of onset of clinical symptoms 
consistent with monkeypox
7
.   
 • The case is determined to be negative for non-variola generic orthopoxvirus by polymerase chain 
reaction testing of a well sampled rash lesion by the approved Laboratory Response Network (LRN) 
protocol. 
 • The case is determined to have undetectable levels of IgM antibody during the period of 7-56 
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1 
Includes living in a household, petting or handling, or visiting a pet holding facility (e.g., pet store, veterinary clinic, pet distributor)  
  
2
 Includes prairie dogs, Gambian giant rats, and rope squirrels. Exposure to other exotic or non-exotic mammalian pets will be 
considered on a case-by-case basis; assessment should include the likelihood of contact with a mammal with monkeypox and the 
compatibility of clinical illness with monkeypox  
  
3
 Includes living in a household, or originating from the same pet holding facility as another animal with monkeypox  
  
4
 Includes skin-to-skin or face-to-face contact  
  
5 
Levels of circulating IgM antibody reactive with orthopoxvirus antigen are determined by ELISA and reported as optical density (OD) 
values.  Values greater than 3 standard deviations above the mean OD of 6 independent negative controls are considered ‘elevated’.  
Serial specimens are not required.  IgM antibody levels may be elevated in persons who have been recently (within one year) 
vaccinated for smallpox.   
 
6 
Factors that might be considered in assigning alternate diagnoses include the strength of the epidemiologic exposure criteria for 
monkeypox, the specificity of the diagnostic test, and the compatibility of the clinical presentation and course of illness for the 
alternative diagnosis.  
 
7
If possible, obtain convalescent-phase serum specimen from these patients. See specimen collection guidelines 
(www.cdc.gov/ncidod/monkeypox/lab.htm ) for details on collecting serum for convalescence evaluation.   
  
8
The optimal timing of specimen collection for determination of IgM levels is between days 7 and 56 post-rash onset.  However, 
elevated levels of IgM antibodies may be detectable prior to day 7, or after day 56, post rash onset, therefore a negative result 





















For more information, visit www.cdc.gov/ncidod/monkeypox  or call the CDC public response hotline at 
(888) 246-2675 (English), (888) 246-2857 (Español), or (866) 874-2646 (TTY)  
 
 
